Tissue Regenix forges distribution agreement for US urogynaecology market

Regenerative medical devices company Tissue Regenix Group said it had entered into an exclusive distribution partnership with ARMS Medical, a specialist in the urogynaecology segment.

The multi-year agreement gave ARMS Medical exclusive rights to distribute the company's DermaPure product to hospitals and surgeons throughout the US for use in urology and gynecology procedures.

At 9:33am: (LON:TRX) Tissue Regenix Group PLC share price was +0.1p at 7.85p